imatinib mesylate has been researched along with Epiphora in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Druker, BJ; Esmaeli, B; Fraunfelder, FW; Kuyl, J; Solomon, J | 1 |
| Ahmadi, MA; Diba, R; Esmaeli, B; Faustina, MM; Fraunfelder, R; Kantarjian, H; Rios, MB; Saadati, HG; Shepler, TR; Talpaz, M | 1 |
2 other study(ies) available for imatinib mesylate and Epiphora
| Article | Year |
|---|---|
Ocular side-effects associated with imatinib mesylate (Gleevec).
Topics: Adult; Aged; Benzamides; Edema; Eye Diseases; Humans; Imatinib Mesylate; Lacrimal Apparatus Diseases; Male; Middle Aged; Piperazines; Pyrimidines; Time Factors; United States | 2003 |
Periorbital oedema and epiphora as ocular side effects of imatinib mesylate (Gleevec).
Topics: Antineoplastic Agents; Benzamides; Edema; Humans; Imatinib Mesylate; Lacrimal Apparatus Diseases; Orbital Diseases; Piperazines; Pyrimidines; Retrospective Studies | 2004 |